{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:07:47Z","timestamp":1793754467678,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humpath.2022.12.014","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T20:51:15Z","timestamp":1672174275000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1644","authenticated-orcid":false,"given":"Jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.12.014_bib1","series-title":"Diagnostic pathology. Lymph nodes and extranodal lymphomas","first-page":"20","article-title":"Chronic granulomatous inflammation","volume":"Vol. 2018","author":"Medeiros","year":"2018"},{"key":"10.1016\/j.humpath.2022.12.014_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200403000-00011","article-title":"Florid granulomatous reaction in Epstein-Barr virus-positive nonendemic Burkitt lymphomas: report of four cases","volume":"28","author":"Haralambieva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/jcp.2004.023911","article-title":"Granulomatous reactions cause symptoms or clinically imitate treatment resistance in small lymphocytic lymphoma\/chronic lymphocytic leukaemia more frequently than in other non-Hodgkin lymphomas","volume":"58","author":"Brunner","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000478-198904000-00002","article-title":"Angioimmunoblastic lymphadenopathy--type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma","volume":"13","author":"Patsouris","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00000478-200210000-00002","article-title":"Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas","volume":"26","author":"Scarabello","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5858\/2000-124-0152-LGBCLA","article-title":"Low-grade B-cell lymphoma and concomitant extensive sarcoidlike granulomas: a case report and review of the literature","volume":"124","author":"Dunphy","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2022.12.014_bib7","first-page":"2772","article-title":"Hodgkin's lymphoma with marked granulomatous reaction: a diagnostic pitfall","volume":"12","author":"Du","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0305-7372(86)90002-2","article-title":"Sarcoid reactions in malignant tumours","volume":"13","author":"Brincker","year":"1986","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.humpath.2022.12.014_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/jama.1975.03260080048020","article-title":"Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign?","volume":"233","author":"O'Connell","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2022.12.014_bib10","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.12.014_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2020.11.002","article-title":"MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma","volume":"108","author":"Lyapichev","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41379-019-0336-3","article-title":"PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma","volume":"33","author":"Shen","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmoldx.2018.08.002","article-title":"Ultra-rapid reporting of GENomic targets (URGENTseq): clinical next-generation sequencing results within 48 hours of sample collection","volume":"21","author":"Patel","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2022.12.014_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/pmj.76.898.457","article-title":"A clinicopathological classification of granulomatous disorders","volume":"76","author":"James","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.humpath.2022.12.014_bib15","first-page":"24","article-title":"Cells and cytokines involved in the pathogenesis of sarcoidosis","volume":"16","author":"Moller","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.humpath.2022.12.014_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1378\/chest.116.2.569","article-title":"Interferon-alpha therapy associated with the development of sarcoidosis","volume":"116","author":"Pietropaoli","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2022.12.014_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAI.0000000000000731","article-title":"Granuloma with an underlying lymphoma: a diagnostic challenge and a wider histologic spectrum including adult T-cell leukemia\/lymphoma","volume":"28","author":"Wu","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.12.014_bib18","first-page":"55","article-title":"Diffuse large B cell lymphoma with chronic granulomatous inflammation","volume":"38","author":"Nyunt","year":"2016","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib19","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","article-title":"The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma","volume":"104","author":"Juszczynski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2022.12.014_bib20","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib21","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.12.014_bib22","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.014_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humpath.2022.12.014_bib24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11899-020-00589-y","article-title":"PD-1\/PD-L1 pathway and its blockade in patients with classic Hodgkin lymphoma and non-hodgkin large-cell lymphomas","volume":"15","author":"Xie","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.humpath.2022.12.014_bib25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood.2020007400","article-title":"Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma","volume":"137","author":"Allen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071587","article-title":"PD-1\/PD-L1 pathway: a therapeutic target in CD30+ large cell lymphomas","volume":"10","author":"Xie","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.humpath.2022.12.014_bib27","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib28","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41375-020-0737-9","article-title":"PD-L1\/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma","volume":"34","author":"Kawashima","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2022.12.014_bib29","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood-2018-03-841015","article-title":"B-cell receptor-mediated NFATc1 activation induces IL-10\/STAT3\/PD-L1 signaling in diffuse large B-cell lymphoma","volume":"132","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib31","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3389\/fimmu.2018.02129","article-title":"Interferon-alpha up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p38 signaling","volume":"9","author":"Bazhin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2022.12.014_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3960\/jslrt.17006","article-title":"Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines","volume":"57","author":"Ma","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.humpath.2022.12.014_bib33","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2022.12.014_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2022.12.014_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41379-018-0152-1","article-title":"Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK\/ERK pathway activation","volume":"32","author":"Garces","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-12-2731","article-title":"The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition","volume":"19","author":"Jiang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.014_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166626","article-title":"RAS-Mitogen-Activated protein kinase signal is required for enhanced PD-L1 expression in human lung cancers","volume":"11","author":"Sumimoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.12.014_bib38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","article-title":"Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease","volume":"30","author":"Garces","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.humpath.2021.12.013","article-title":"Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase\/extracellular signal-regulated kinase pathway activation","volume":"121","author":"Garces","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.014_bib40","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.12.014_bib41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.12.014_bib42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/10428194.2014.917636","article-title":"CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment","volume":"56","author":"Touati","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.12.014_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000321567","article-title":"Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma","volume":"77","author":"Tzankov","year":"2010","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2022.12.014_bib44","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3109\/10428194.2014.963081","article-title":"CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma","volume":"56","author":"Agur","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2022.12.014_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/annonc\/mdr157","article-title":"Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma","volume":"23","author":"Azambuja","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.12.014_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/hon.2249","article-title":"Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment","volume":"35","author":"Cencini","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2022.12.014_bib47","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.1038\/s41598-020-66010-z","article-title":"Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome","volume":"10","author":"Werner","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2022.12.014_bib48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197802)41:2<562::AID-CNCR2820410224>3.0.CO;2-X","article-title":"Epithelioid granulomas associated with Hodgkin's disease: clinical correlations in 55 previously untreated patients","volume":"41","author":"Sacks","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.12.014_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0142(19800115)45:2<289::AID-CNCR2820450215>3.0.CO;2-S","article-title":"The histology of the initial relapse of Hodgkin's disease","volume":"45","author":"Colby","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.12.014_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100949","article-title":"A review of pathobiology and therapies for classic Hodgkin lymphoma","volume":"55","author":"Khan","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.humpath.2022.12.014_bib51","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.12.014_bib52","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1056\/NEJMc0906731","article-title":"Long-term follow-up of survival in Hodgkin's lymphoma","volume":"361","author":"Canellos","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:40Z","timestamp":1758645640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"alternative-id":["S0046817722002921"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.014","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}